Precision Biotech Part 2: How Is Our Medical Data Analyzed?

The last several weeks we’ve been focusing on wearable devices that monitor your health and the precision medicine initiative, which focuses on high-tech means and methods for archiving your biological data for advanced and customized medicine.

Let’s turn our attention to where the data from these wearable devices and traditional lab testing equipment would go for analysis.  Part of the precision medicine initiative is to develop a voluntary national research cohort of a million or more people to donate their medical data for analysis and development of better precision treatments and medicine.

There will be a secure government database containing a million or more medical files that contain essential information for doctors to review. These files would include genes, metabolites (chemical make-up), microorganisms, environmental, and lifestyle data.

All of which help doctors to diagnose and treat their patients more efficiently.

You may be skeptical because you’ve seen that the Veterans Administration (VA) has been featured in several news segments covering their poor handling of medical records. And you have a point.

But here’s where we turn away from a government-owned facility to one that is private.

The private industry is currently developing precision medicine-type analysis centers where genomes can be mapped and stored on a smaller scale.

This data will greatly enhance the diagnosis and treatment options for a variety of horrible diseases, with cancer being one of the most formidable foes.  The formerly profiled NantWorks conglomerate is only one of a handful of companies that intends to fight cancer with this precision technology.

There will be constant changes in stockpiling this type of medical data… the primary reason being privacy options. But there is an upside to providing this important medical information.

It gives doctors solid statistics in order to diagnose and treat ailments that crop up in any given patient. They’ll be able to compare the chemical and biological make-up of the patients in question, and be able to treat them in a more efficient and targeted manner.

If you’ve missed the first part of this series, you can read up on this important feature that has cropped up in our health care system. It’ll be an essential part of lives in just a few short years and will serve to enhance the care we get from our doctors.

If you’re interested in learning more about game-changing bio-news and would like to take advantage of the market plays available, check out the latest health and biotech technology trends through my Biotech Intel Trader service. Click here for more information.

Image Signature

Ben

P.S. For those of you who have missed my previous articles, you can read up on everything here.

Categories: Biotech

About Author

Ben Benoy is a veteran of the U.S. Marine Corps and has been an active retail trader since 2006. He identifies investment opportunities based on key social media trends. He first identified the concept in 2008 and has since developed a tool for tracking investment “chatter” between social media users. His proprietary Social Media Stock Sentiment system has developed into a state-of-the-art platform that identifies and classifies chatter about stocks through algorithms and other indicators to forecast stock-price direction. Ben’s track record speaks for itself — over the past 12 months, his system boasts a win rate of 82.2% on 112 stock trades.